Yuan‐Yeh Kuo

3.3k total citations
56 papers, 1.3k citations indexed

About

Yuan‐Yeh Kuo is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Yuan‐Yeh Kuo has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 27 papers in Genetics and 23 papers in Molecular Biology. Recurrent topics in Yuan‐Yeh Kuo's work include Acute Myeloid Leukemia Research (34 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers) and Kruppel-like factors research (7 papers). Yuan‐Yeh Kuo is often cited by papers focused on Acute Myeloid Leukemia Research (34 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers) and Kruppel-like factors research (7 papers). Yuan‐Yeh Kuo collaborates with scholars based in Taiwan, United States and Singapore. Yuan‐Yeh Kuo's co-authors include Fengsheng Su, Hwei‐Fang Tien, Wen‐Chien Chou, Hsiao‐Huei Chen, Hsin‐An Hou, Jih‐Luh Tang, Ching‐Hua Kuo, Zee-Fen Chang, Mei‐Hsuan Tseng and Ming Yao and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yuan‐Yeh Kuo

49 papers receiving 1.2k citations

Peers

Countries citing papers authored by Yuan‐Yeh Kuo

Since Specialization

Citations

This map shows the geographic impact of Yuan‐Yeh Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Yeh Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Yeh Kuo more than expected).

Fields of papers citing papers by Yuan‐Yeh Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan‐Yeh Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Yeh Kuo. The network helps show where Yuan‐Yeh Kuo may publish in the future.

Co-authorship network of co-authors of Yuan‐Yeh Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan‐Yeh Kuo. A scholar is included among the top collaborators of Yuan‐Yeh Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan‐Yeh Kuo. Yuan‐Yeh Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IDH2 mutation accelerates TPO‐induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo 2024 ·SHILAP Revista de lepidopterología ·Chien‐Chin Lin, Chi‐Yuan Yao, (unknown), (unknown), Chang‐Tsu Yuan, (unknown), Chia‐Lang Hsu, (unknown), (unknown), (unknown), (unknown), (unknown), Yuan‐Yeh Kuo, Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	0
2	Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations 2024 ·Blood Cancer Journal ·Feng‐Ming Tien, Chi‐Yuan Yao, Cheng‐Hong Tsai, (unknown), Chien‐Yuan Chen, (unknown), Chien‐Chin Lin, Yuan‐Yeh Kuo, Yen‐Ling Peng, Mei‐Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang‐In Lin, (unknown), Bor‐Sheng Ko, Ming Yao, Jih‐Luh Tang, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	8
3	Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms 2024 ·Blood Cancer Journal ·(unknown), Chien‐Chin Lin, Cheng‐Hong Tsai, Feng‐Ming Tien, (unknown), Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, (unknown), Ming-Chih Liu, Chang‐Tsu Yuan, (unknown), (unknown), Bor‐Sheng Ko, Jih‐Luh Tang, (unknown), (unknown), Hwei‐Fang Tien, Hsin‐An Hou, Wen‐Chien Chou	7
4	Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification 2023 ·Blood Cancer Journal ·(unknown), (unknown), Cheng‐Hong Tsai, Feng‐Ming Tien, (unknown), Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, Ming-Chih Liu, (unknown), (unknown), Jih‐Luh Tang, (unknown), (unknown), Liang‐In Lin, Wen‐Chien Chou, Chien‐Chin Lin, Hsin‐An Hou, Hwei‐Fang Tien	12
5	Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML 2023 ·Blood Cancer Journal ·Cheng‐Hong Tsai, (unknown), (unknown), Feng‐Ming Tien, Yuan‐Yeh Kuo, Mei‐Hsuan Tseng, Yen‐Ling Peng, (unknown), Bor‐Sheng Ko, Jih‐Luh Tang, (unknown), Ming-Chih Liu, Chia‐Wen Liu, Chien‐Chin Lin, Ming Yao, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	17
6	Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification 2023 ·American Journal of Hematology ·(unknown), Chien‐Chin Lin, Cheng‐Hong Tsai, Feng‐Ming Tien, (unknown), (unknown), Ming Yao, Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, (unknown), Jih‐Luh Tang, (unknown), (unknown), Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	6
7	Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification 2023 ·Blood ·(unknown), (unknown), Chien‐Chin Lin, Cheng‐Hong Tsai, Feng‐Ming Tien, (unknown), Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, (unknown), Ming-Chih Liu, Chang‐Tsu Yuan, (unknown), (unknown), Jih‐Luh Tang, (unknown), (unknown), Hsin‐An Hou, Hwei‐Fang Tien, Wen‐Chien Chou	1
8	Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia 2023 ·American Journal of Hematology ·(unknown), Cheng‐Hong Tsai, Chien‐Chin Lin, Feng‐Ming Tien, Yuan‐Yeh Kuo, (unknown), Yen‐Ling Peng, (unknown), Mei‐Hsuan Tseng, (unknown), (unknown), Liang‐In Lin, (unknown), (unknown), Bor‐Sheng Ko, Jih‐Luh Tang, Ming Yao, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	19
9	Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis 2022 ·Annals of Hematology ·(unknown), Chi‐Yuan Yao, (unknown), Chien‐Ting Lin, Marcus J. Calkins, Yuan‐Yeh Kuo, Jih‐Luh Tang, Hwei‐Fang Tien, Shang‐Ju Wu	5
10	Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML 2021 ·Blood Advances ·Cheng‐Hong Tsai, Jih‐Luh Tang, Feng‐Ming Tien, Yuan‐Yeh Kuo, (unknown), Chien‐Chin Lin, Mei‐Hsuan Tseng, Yen‐Ling Peng, (unknown), (unknown), Ming-Chih Liu, Chia‐Wen Liu, Ming Yao, Liang‐In Lin, Wen‐Chien Chou, Chien‐Yu Chen, Hsin‐An Hou, Hwei‐Fang Tien	38
11	Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients 2019 ·EBioMedicine ·Cheng‐Hong Tsai, Chi‐Yuan Yao, (unknown), Jih‐Luh Tang, Yuan‐Yeh Kuo, Yu‐Chiao Chiu, Chien‐Chin Lin, Mei‐Hsuan Tseng, Yen‐Ling Peng, Ming-Chih Liu, Chia‐Wen Liu, Ming Yao, Liang‐In Lin, Wen‐Chien Chou, Chien‐Yu Chen, Hsin‐An Hou, Hwei‐Fang Tien	26
12	Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia 2017 ·Haematologica ·Chien‐Chin Lin, (unknown), (unknown), Yuan‐Yeh Kuo, Hsin‐An Hou, Keng‐Hsin Lan, (unknown), Yi-Shiuan Tzeng, (unknown), (unknown), (unknown), Mei‐Hsuan Tseng, Yu‐Chiao Chiu, Wen‐Chien Chou, Hwei‐Fang Tien	35
13	Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms 2017 ·Medical Oncology ·Yu‐Cheng Chang, (unknown), (unknown), (unknown), Ling Huang, Wei‐Ting Wang, Chun‐Chia Cheng, Johnson Lin, Yi‐Fang Chang, Ming‐Chih Chang, Ruey-Kuen Hsieh, Shu‐Jen Chen, Ken‐Hong Lim, Yuan‐Yeh Kuo	29
14	Expression of CALR mutants causes mpl-dependent thrombocytosis in zebrafish 2016 ·Blood Cancer Journal ·Ken‐Hong Lim, (unknown), (unknown), (unknown), (unknown), Chang‐Shen Lin, (unknown), Wentao Wang, (unknown), Wen‐Chien Chou, Yuan‐Yeh Kuo	18
15	CALR Mutations in Myeloproliferative Neoplasms 2014 ·International journal of gerontology ·Ken‐Hong Lim, (unknown), (unknown), (unknown), Chung‐Der Hsiao, Yuan‐Yeh Kuo	3
16	The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression 2014 ·Haematologica ·Yuan‐Yeh Kuo, Hsin‐An Hou, Yao-Shen Chen, Long‐Yuan Li, Ping‐Hei Chen, (unknown), Chih‐Fen Huang, (unknown), (unknown), C. W. Liu, Wen‐Chien Chou, (unknown), Jih‐Luh Tang, Ming Yao, Hwei‐Fang Tien	10
17	Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles 2008 ·International Journal of Pharmaceutics ·Yuan‐Yeh Kuo, Hsiao‐Huei Chen	86
18	Transport of stavudine, delavirdine, and saquinavir across the blood–brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles 2007 ·International Journal of Pharmaceutics ·Yuan‐Yeh Kuo, Fengsheng Su	122
19	Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability 2005 ·Genes & Development ·Po‐Yuan Ke, Yuan‐Yeh Kuo, (unknown), Zee-Fen Chang	73
20	GB irus C/hepatitis G virus infection in patients on continuous ambulatory peritoneal dialysis 1998 ·Nephrology Dialysis Transplantation ·Chao‐Yuan Huang, Jia‐Horng Kao, Yuan‐Yeh Kuo, Tun‐Jun Tsai, Kuan‐Yu Hung, Ding‐Shinn Chen	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact